Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation

McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195 · see citing works

PEAR: a fast and accurate Illumina Paired-End reAd mergeR

Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497 · see citing works

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116 · see citing works

Assessment of psychotropic-like properties of a probiotic formulation ( <i>Lactobacillus helveticus</i> R0052 and <i>Bifidobacterium longum</i> R0175) in rats and human subjects

Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.-F., Rougeot, C., Pichelin, M., Cazaubiel, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114510004319 · Cited by 1,324 · see citing works

Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies: Mortality among opioid users

Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., & McLaren, J. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03140.x · Cited by 856 · see citing works

Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome

Pinto-Sanchez, M. I., Hall, G. B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J. T., Martin, F.-P., Cominetti, O., Welsh, C., Rieder, A., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.003 · Cited by 821 · see citing works

Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study

Murri, M., Leiva, I., Gómez‐Zumaquero, J. M., Tinahones, F. J., Cardona, F., Soriguer, F., & Queipo‐Ortuño, M. I. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-46 · Cited by 767 · see citing works

Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading <i>Akkermansia muciniphila</i> and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut

de la Cuesta-Zuluaga, J., Mueller, N. T., Corrales-Agudelo, V., Velásquez-Mejía, E. P., Carmona, J. A., Abad, J. M., & Escobar, J. S. (2017) · Diabetes Care · doi:10.2337/dc16-1324 · Cited by 704 · see citing works

Strengths and Limitations of 16S rRNA Gene Amplicon Sequencing in Revealing Temporal Microbial Community Dynamics

Poretsky, R., Rodriguez-R, L. M., Luo, C., Tsementzi, D., & Konstantinidis, K. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093827 · Cited by 684 · see citing works

Probiotic yogurt improves antioxidant status in type 2 diabetic patients

Ejtahed, H. S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., & Mofid, V. (2012) · Nutrition · doi:10.1016/j.nut.2011.08.013 · Cited by 683 · see citing works

Stress as a Common Risk Factor for Obesity and Addiction

Sinha, R., & Jastreboff, A. M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.032 · Cited by 611 · see citing works

Molecular Characterisation of the Faecal Microbiota in Patients with Type II Diabetes

Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., Yu, P., Zhao, C., Li, L., Zhou, A., et al. (2010) · Current Microbiology · doi:10.1007/s00284-010-9582-9 · Cited by 461 · see citing works

Standards of Medical Care in Diabetes—2017 : Summary of Revisions

(2016) · Diabetes Care · doi:10.2337/dc17-s003 · Cited by 425 · see citing works

Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment

Gu, Y., Wang, X., Li, J., Zhang, Y., Zhong, H., Liu, R., Zhang, D., Feng, Q., Xie, X., Hong, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01682-2 · Cited by 396 · see citing works

Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study

Tonucci, L. B., dos Santos, K. M. O., de Oliveira, L. L., Ribeiro, S. M. R., & Martino, H. S. D. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.11.011 · Cited by 389 · see citing works

GABA production and structure of gadB / gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota

Yunes, R. А., Poluektova, E. U., Dyachkova, M. S., Klimina, K. M., Kovtun, A. S., Averina, O. V., Orlova, V. S., & Даниленко, В. Н. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.10.011 · Cited by 376 · see citing works

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

Bandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190867 · Cited by 347 · see citing works

Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin

Poutahidis, T., Kearney, S. M., Levkovich, T., Qi, P., Varian, B. J., Lakritz, J. R., Ibrahim, Y. M., Chatzigiagkos, A., Alm, E. J., & Erdman, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078898 · Cited by 310 · see citing works

The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment: Relationship to Depression, Anxiety, and Eating Disorder Psychopathology

Kleiman, S. C., Watson, H. J., Bulik-Sullivan, E. C., Huh, E. Y., Tarantino, L. M., Bulik, C. M., & Carroll, I. M. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000247 · Cited by 303 · see citing works

An atlas of β-glucuronidases in the human intestinal microbiome

Pollet, R. M., D'Agostino, E. H., Walton, W. G., Xu, Y., Little, M. S., Biernat, K. A., Pellock, S. J., Patterson, L. M., Creekmore, B. C., Isenberg, H. N., et al. (2017) · Structure · doi:10.1016/j.str.2017.05.003 · Cited by 289 · see citing works

Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity

Wallace, B. D., Roberts, A. B., Pollet, R. M., Ingle, J. D., Biernat, K. A., Pellock, S. J., Venkatesh, M. K., Guthrie, L., O’Neal, S. K., Robinson, S. J., et al. (2015) · Chemistry &amp; Biology · doi:10.1016/j.chembiol.2015.08.005 · Cited by 285 · see citing works

Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study

Dujić, T., Zhou, K., Donnelly, L. A., Tavendale, R., Palmer, C. N. A., & Pearson, E. R. (2014) · Diabetes · doi:10.2337/db14-1388 · Cited by 283 · see citing works

Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation

Banerjee, S., Sindberg, G., Wang, F., Meng, J., Sharma, U., Zhang, L., Dauer, P., Chen, C., Dalluge, J., Johnson, T., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.9 · Cited by 266 · see citing works

Alterations of the Host Microbiome Affect Behavioral Responses to Cocaine

Kiraly, D. D., Walker, D. M., Calipari, E. S., Labonté, B., Issler, O., Peña, C. J., Ribeiro, E., Russo, S. J., & Nestler, E. J. (2016) · Scientific Reports · doi:10.1038/srep35455 · Cited by 264 · see citing works

The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c

Christensen, M. M. H., Brasch‐Andersen, C., Gréen, H., Nielsen, F., Damkier, P., Beck‐Nielsen, H., & Brøsen, K. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834c0010 · Cited by 258 · see citing works

Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus

Moroti, C., Magri, L. F. S., Costa, M. D. R., Cavallini, D., & Sivieri, K. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-29 · Cited by 254 · see citing works

Deconstructing the Polymerase Chain Reaction: Understanding and Correcting Bias Associated with Primer Degeneracies and Primer-Template Mismatches

Green, S. J., Venkatramanan, R., & Naqib, A. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128122 · Cited by 209 · see citing works

Gut microbiome composition is associated with temperament during early childhood

Christian, L. M., Galley, J. D., Hade, E. M., Schoppe-Sullivan, S., Kamp Dush, C., & Bailey, M. T. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.10.018 · Cited by 191 · see citing works

Lactobacillus casei CCFM419 attenuates type 2 diabetes via a gut microbiota dependent mechanism

Wang, G., Li, X., Zhao, J., Zhang, H., & Chen, W. (2017) · Food & Function · doi:10.1039/c7fo00593h · Cited by 172 · see citing works

Fecal Bacterial β-Glucuronidase: Control by Diet

Reddy, B. S., Weisburger, J. H., & Wynder, E. L. (1974) · Science · doi:10.1126/science.183.4123.416 · Cited by 166 · see citing works

Impact of Westernized Diet on Gut Microbiota in Children on Leyte Island

Nakayama, J., Yamamoto, A., Conde, L. A., Higashi, K., Sonomoto, K., Tan, J. D., & Lee, Y. K. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00197 · Cited by 163 · see citing works

Gut Microbiota, Prebiotics, Probiotics, and Synbiotics in Management of Obesity and Prediabetes: Review of Randomized Controlled Trials

Barengolts, E. I. (2016) · Endocrine Practice · doi:10.4158/ep151157.ra · Cited by 143 · see citing works

Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes

Dujić, T., Causevic, A., Bego, T., Malenica, M., Velija-Ašimi, Z., Pearson, E. R., & Semiz, S. (2015) · Diabetic Medicine · doi:10.1111/dme.13040 · Cited by 138 · see citing works

Gut Homeostasis, Microbial Dysbiosis, and Opioids

Wang, F., & Roy, S. (2016) · Toxicologic Pathology · doi:10.1177/0192623316679898 · Cited by 128 · see citing works

Posttraumatic stress disorder: does the gut microbiome hold the key?

Leclercq, S., Forsythe, P., & Bienenstock, J. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716635535 · Cited by 121 · see citing works

Association of Intestinal Microbiota with Metabolic Markers and Dietary Habits in Patients with Type 2 Diabetes

Yamaguchi, Y., Adachi, K., Sugiyama, T., Shimozato, A., Ebi, M., Ogasawara, N., Funaki, Y., Goto, C., Sasaki, M., & Kasugai, K. (2016) · Digestion · doi:10.1159/000447690 · Cited by 119 · see citing works

A Randomized Controlled Clinical Trial Investigating the Effect of Synbiotic Administration on Markers of Insulin Metabolism and Lipid Profiles in Overweight Type 2 Diabetic Patients with Coronary Heart Disease

Ebrahimi, M. T., Sharifi, N., Farrokhian, A., Raygan, F., Karamali, F., Razzaghi, R., Taheri, S., & Asemi, Z. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-105441 · Cited by 116 · see citing works

Stress-Induced Elevation of Oxytocin in Maltreated Children: Evolution, Neurodevelopment, and Social Behavior

Seltzer, L. J., Ziegler, T. E., Connolly, M. J., Prososki, A. R., & Pollak, S. D. (2013) · Child Development · doi:10.1111/cdev.12136 · Cited by 108 · see citing works

Bidirectional interactions between indomethacin and the murine intestinal microbiota

Liang, X., Bittinger, K. L., Li, X., Abernethy, D. R., Bushman, F. D., & FitzGerald, G. A. (2015) · eLife · doi:10.7554/elife.08973 · Cited by 101 · see citing works

GABAergic system in the endocrine pancreas: a new target for diabetes treatment

Wang, Q., Prud'homme, G., & Wan, Y. (2015) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s50642 · Cited by 100 · see citing works

Significant differences in fecal microbiota are associated with various stages of glucose tolerance in African American male veterans

Ciubotaru, I., Green, S. J., Kukreja, S. C., & Barengolts, E. I. (2015) · Translational research · doi:10.1016/j.trsl.2015.06.015 · Cited by 87 · see citing works

The Potential of Pregabalin in Neurology, Psychiatry and Addiction: A Qualitative Overview

Martinotti, G., Lupi, M., Sarchione, F., Santacroce, R., Salone, A., Berardis, D. D., Serroni, N., Cavuto, M., Signorelli, M. S., Aguglia, E., et al. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990425 · Cited by 72 · see citing works

Chronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in Obesity

Altirriba, J., Poher, A.-L., & Rohner‐Jeanrenaud, F. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00119 · Cited by 63 · see citing works

Effect of High-Dose Vitamin D Repletion on Glycemic Control in African-American Males with Prediabetes and Hypovitaminosis D

Barengolts, E. I., Manickam, B., Eisenberg, Y., Akbar, A., Kukreja, S. C., & Ciubotaru, I. (2015) · Endocrine Practice · doi:10.4158/ep14548.or · Cited by 57 · see citing works

Effects of Probiotic Lactobacillus paracasei-enriched Artichokes on Constipated Patients

Valerio, F., Russo, F., de Candia, S., Riezzo, G., Orlando, A., Lonigro, S. L., & Lavermicocca, P. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181d2dca4 · Cited by 40 · see citing works

American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome

Semenkovich, C. F., Danska, J. S., Darsow, T., Dunne, J. L., Huttenhower, C., Insel, R. A., McElvaine, A. T., Ratner, R. E., Shuldiner, A. R., & Blaser, M. J. (2015) · Diabetes · doi:10.2337/db15-0597 · Cited by 36 · see citing works

Leptin Levels and Depressive Symptoms in People With Type 2 Diabetes

Labad, J., Price, J. F., Strachan, M. W. J., Fowkes, F. G. R., Deary, I. J., Seckl, J. R., Walker, B. R., Sattar, N. A., & Reynolds, R. M. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31823ba8af · Cited by 25 · see citing works

Environment-Related Adaptive Changes of Gut Commensal Microbiota Do not Alter Colonic Toll-Like Receptors but Modulate the Local Expression of Sensory-Related Systems in Rats

Aguilera, M., Vergara, P., & Martı́nez, V. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0241-0 · Cited by 22 · see citing works

Oxytocin - An Emerging Treatment for Obesity and Dysglycemia: Review of Randomized Controlled Trials and Cohort Studies

Barengolts, E. I. (2016) · Endocrine Practice · doi:10.4158/ep151192.ra · Cited by 21 · see citing works

Early Discontinuation of Metformin in Individuals Treated with Inhibitors of Transporters of Metformin

Stage, T. B., Lee, M. P., Hallas, J., Christensen, M. M. H., Brøsen, K., Christensen, K., Gagne, J. J., & Pottegård, A. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12579 · Cited by 9 · see citing works

Defining ‘good health’

Erdman, S. E. (2016) · Aging · doi:10.18632/aging.101154 · Cited by 6 · see citing works

Role of gut microbiota in type 2 diabetes pathophysiology

Gurung, M., Li, Z., You, H. M., Rodrigues, R. R., Jump, D. Β., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,741 · see citing works

Gut microbiota in patients with obesity and metabolic disorders — a systematic review

Xu, Z., Jiang, W., Huang, W., Lin, Y., Chan, F. K. L., & Ng, S. C. (2022) · Genes & Nutrition · doi:10.1186/s12263-021-00703-6 · Cited by 248 · see citing works

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus

Zhang, Q., & Hu, N. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s286430 · Cited by 185 · see citing works

Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome

Zhang, L., Meng, J., Ban, Y. J., Jalodia, R., Chupikova, I., Fernández, I., Brito, N., Sharma, U., Abreu, M. T., Ramakrishnan, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901182116 · Cited by 160 · see citing works

A potential role for the gut microbiome in substance use disorders

Meckel, K. R., & Kiraly, D. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05232-0 · Cited by 141 · see citing works

Metabolic Effects of Oxytocin

McCormack, S. E., Blevins, J. E., & Lawson, E. A. (2019) · Endocrine Reviews · doi:10.1210/endrev/bnz012 · Cited by 140 · see citing works

Metformin and gut microbiota: their interactions and their impact on diabetes

Vallianou, N. G., Stratigou, T., & Tsagarakis, S. (2019) · Hormones · doi:10.1007/s42000-019-00093-w · Cited by 138 · see citing works

Mining microbes for mental health: determining the role of microbial metabolic pathways in human brain health and disease

Spichak, S., Bastiaanssen, T. F. S., Berding, K., Vlckova, K., Clarke, G., Dinan, T. G., & Cryan, J. F. (2021) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.044 · Cited by 127 · see citing works

Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation

Su, L., Hong, Z., Zhou, T., Jian, Y., Xu, M., Zhang, X., Zhu, X., & Wang, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-05127-9 · Cited by 114 · see citing works

Effects of metformin on the gut microbiota: A systematic review

Petakh, P., Kamyshna, I. I., & Kamyshnyi, O. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101805 · Cited by 105 · see citing works

Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain

Zádori, Z., Király, K. P., Al‐Khrasani, M., & Gyires, K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108327 · Cited by 90 · see citing works

The combined effects of probiotics and restricted calorie diet on the anthropometric indices, eating behavior, and hormone levels of obese women with food addiction: a randomized clinical trial

Narmaki, E., Borazjani, M., Ataie‐Jafari, A., Hariri, N., Doost, A. H., Qorbani, M., & Saidpour, A. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1826763 · Cited by 82 · see citing works

Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis

Zhang, E., Jin, L., Wang, Y., Tu, J., Zheng, R., Ding, L., Fang, Z., Fan, M., Al-Abdullah, I., Natarajan, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28743-5 · Cited by 76 · see citing works

Estradiol and high fat diet associate with changes in gut microbiota in female ob/ob mice

Acharya, K. D., Gao, X., Bless, E. P., Chen, J., & Tetel, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-56723-1 · Cited by 74 · see citing works

Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity

Cruz-Lebrón, A., Johnson, R., Mazahery, C., Troyer, Z., Joussef-Piña, S., Quiñones‐Mateu, M. E., Strauch, C., Hazen, S. L., & Levine, A. D. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1946368 · Cited by 73 · see citing works

The role of the gut microbiome in opioid use

Ren, M., & Lotfipour, S. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000538 · Cited by 68 · see citing works

Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment

Gicquelais, R. E., Bohnert, A. M., Thomas, L., & Foxman, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-76570-9 · Cited by 64 · see citing works

Opioid system influences gut-brain axis: Dysbiosis and related alterations

Rueda‐Ruzafa, L., Cruz, F., Cardona, D., Hone, A. J., Molina‐Torres, G., Sánchez‐Labraca, N., & Román, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104928 · Cited by 64 · see citing works

Blood-Glucose-Lowering Effect of Coptidis Rhizoma Extracts From Different Origins via Gut Microbiota Modulation in db/db Mice

Lyu, Y., Lin, L., Xie, Y., Li, D. X., Xiao, M., Zhang, Y., Cheung, S. C. K., Shaw, P. C., Yang, X., Chan, P. K. S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.684358 · Cited by 60 · see citing works

Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders

Simpson, S., Mclellan, R., Wellmeyer, E., Matalon, F., & George, O. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10022-7 · Cited by 61 · see citing works

Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use

Kolli, U., Jalodia, R., Moidunny, S., Singh, P. K., Ban, Y. J., Tao, J., Cantu, G. N., Valdes, E., Ramakrishnan, S., & Roy, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2246184 · Cited by 59 · see citing works

Gastrointestinal motility, dysbiosis and opioid-induced tolerance: is there a link?

Akbarali, H. I., & Dewey, W. L. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0150-x · Cited by 54 · see citing works

Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies

Cao, T. T. B., Wu, K., Hsu, J., Chang, C., Chou, C., Lin, C.-Y., Liao, Y.-M., Lin, P.-C., Yang, L., & Lin, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573891 · Cited by 49 · see citing works

An altered microbiota pattern precedes Type 2 diabetes mellitus development: From the CORDIOPREV study

Vals‐Delgado, C., Alcala-Diaz, J. F., Molina‐Abril, H., Roncero‐Ramos, I., Caspers, M. P. M., Schuren, F. H. J., van den Broek, T. J., Luque, R. M., Pérez‐Martínez, P., Katsiki, N., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.05.001 · Cited by 49 · see citing works

The effects of microbiota on reproductive health: A review

Wang, N., Chen, L., Yi, K., Zhang, B., Li, C., & Zhou, X. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2117784 · Cited by 49 · see citing works

Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice

Thomaz, A. C., Iyer, V., Woodward, T. J., & Hohmann, A. G. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113787 · Cited by 46 · see citing works

Drug-Drug Interactions at Organic Cation Transporter 1

Zhou, S., Zeng, S., & Shu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.628705 · Cited by 46 · see citing works

Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites

Wang, D., Liu, J. Y., Zhou, L., Zhang, Q., Li, M., & Xiao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.905171 · Cited by 46 · see citing works

A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health

Wiss, D. A. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00193 · Cited by 41 · see citing works

The Gut Microbiota-Related Antihyperglycemic Effect of Metformin

Szymczak-Pajor, I., Drzewoski, J., Kozłowska, M., Krekora, J., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18010055 · Cited by 41 · see citing works

Combing fecal microbial community data to identify consistent obesity-specific microbial signatures and shared metabolic pathways

Lin, Y., Xu, Z., Yeoh, Y. K., Tun, H. M., Huang, W., Jiang, W., Chan, F. K. L., & Ng, S. C. (2023) · iScience · doi:10.1016/j.isci.2023.106476 · Cited by 37 · see citing works

Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System

Jalodia, R., Abu, Y. F., Oppenheimer, M. R., Truitt, B., Meng, J., Chupikova, I., Tao, J., Ghosh, N., Dutta, R. K., Kolli, U., et al. (2022) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10046-z · Cited by 35 · see citing works

Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes

Barengolts, E. I., Green, S. J., Chlipala, G. E., Layden, B. T., Eisenberg, Y., Priyadarshini, M., & Dugas, L. R. (2019) · Microorganisms · doi:10.3390/microorganisms7090320 · Cited by 33 · see citing works

Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword

Petakh, P., Kamyshna, I. I., Nykyforuk, A., Yao, R., Imbery, J. F., Oksenych, V., Korda, M. M., & Kamyshnyi, O. (2022) · Viruses · doi:10.3390/v14030477 · Cited by 32 · see citing works

Bridging the gap: associations between gut microbiota and psychiatric disorders

Ahmed, G. K., Ramadan, H. K., Elbeh, K., & Haridy, N. A. (2024) · Middle East Current Psychiatry · doi:10.1186/s43045-024-00395-9 · Cited by 32 · see citing works

The Microbiome–Gut–Brain Axis, a Potential Therapeutic Target for Substance-Related Disorders

Fu, X., Chen, T., Cai, J., Liu, B., Zeng, Y., & Zhang, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.738401 · Cited by 28 · see citing works

Effect of cinnamon spice on continuously monitored glycemic response in adults with prediabetes: a 4-week randomized controlled crossover trial

Zelicha, H., Yang, J., Henning, S. M., Huang, J., Lee, R., Thames, G., Livingston, E. H., Heber, D., & Li, Z. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.01.008 · Cited by 27 · see citing works

Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study

Glaros, S. B., Mishra, S. P., Jain, S., Davis, F., Gabel, S. A., Mueller, G. A., Jarmusch, A. K., Mabundo, L. S., Courville, A. B., Walter, M. F., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2558071 · Cited by 30 · see citing works

Dose- and Sex-Dependent Bidirectional Relationship between Intravenous Fentanyl Self-Administration and Gut Microbiota

Ren, M., & Lotfipour, S. (2022) · Microorganisms · doi:10.3390/microorganisms10061127 · Cited by 27 · see citing works

The Effects of Probiotic Supplementation on Opioid‐Related Disorder in Patients under Methadone Maintenance Treatment Programs

Molavi, N., Rasouli‐Azad, M., Mirzaei, H., Matini, A. H., Banafshe, H. R., Valiollahzadeh, M., Hassanzadeh, M., Saghazade, A. R., Abbaszadeh‐Mashkani, S., Mamsharifi, P., et al. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/1206914 · Cited by 26 · see citing works

Substance use, microbiome and psychiatric disorders

Chivero, E. T., Sil, S., Kumar, M., & Buch, S. J. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173432 · Cited by 24 · see citing works

Effect of a 12-Week Polyphenol Rutin Intervention on Markers of Pancreatic β-Cell Function and Gut Microbiota in Adults with Overweight without Diabetes

Mathrani, A., Yip, W. C. Y., Sequeira, I. R., Barnett, D., Stevenson, O. G., Taylor, M. W., & Poppitt, S. D. (2023) · Nutrients · doi:10.3390/nu15153360 · Cited by 25 · see citing works

Insights into the gut microbiota of Nigerian elderly with type 2 diabetes and non-diabetic elderly persons

Afolayan, A. O., Adebusoye, L. A., Cadmus, E., & Ayeni, F. A. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03971 · Cited by 23 · see citing works

Long-Term Effects of Developmental Exposure to Oxycodone on Gut Microbiota and Relationship to Adult Behaviors and Metabolism

Lyu, Z., Schmidt, R., Martin, R. E., Green, M. T., Kinkade, J. A., Mao, J., Bivens, N. J., Joshi, T., & Rosenfeld, C. S. (2022) · mSystems · doi:10.1128/msystems.00336-22 · Cited by 22 · see citing works

The role of morphine‐ and fentanyl‐induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota‐gut‐brain axis

Muchhala, K. H., Kallurkar, P. S., Kang, M., Köşeli, E., Poklis, J. L., Xu, Q., Dewey, W. L., Fettweis, J. M., Jimenez, N. R., & Akbarali, H. I. (2024) · The FASEB Journal · doi:10.1096/fj.202301590rr · Cited by 22 · see citing works

Association of diabetes and microbiota: An update

Al-Jameel, S. S. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.04.041 · Cited by 22 · see citing works

Prospective evaluation of probiotic and prebiotic supplementation on diabetic health associated with gut microbiota

Khalil, N. A., El-Tahan, N. R., Elaktash, H. M., Aly, S., & Sarbini, S. R. (2021) · Food Bioscience · doi:10.1016/j.fbio.2021.101149 · Cited by 21 · see citing works

Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome

He, D., Han, H., Fu, X., Liu, A., Zhan, Y., Qiu, H., Ma, L., Zhang, X., & Wang, X. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.08.001 · Cited by 21 · see citing works

Substrates and Inhibitors of Organic Cation Transporters (OCTs) and Plasma Membrane Monoamine Transporter (PMAT) and Therapeutic Implications

Bönisch, H. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_516 · Cited by 21 · see citing works

Role of microbes in the pathogenesis of neuropsychiatric disorders

Goswami, A., Wendt, F. R., Pathak, G. A., Tylee, D. S., Angelis, F. D., Lillo, A. D., & Polimanti, R. A. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100917 · Cited by 20 · see citing works

Design of the Building Research in CRC prevention (BRIDGE-CRC) trial: a 6-month, parallel group Mediterranean diet and weight loss randomized controlled lifestyle intervention targeting the bile acid-gut microbiome axis to reduce colorectal cancer risk among African American/Black adults with obesity

McLeod, A., Wolf, P. G., Chapkin, R. S., Davidson, L. A., Ivanov, I. V., Berbaum, M. L., Williams, L. R., Gaskins, H. R., Ridlon, J. M., Sanchez-Flack, J., et al. (2023) · Trials · doi:10.1186/s13063-023-07115-4 · Cited by 19 · see citing works

The Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review

Diotaiuti, P., Misiti, F., Marotta, G., Falese, L., Calabrò, G. E., & Mancone, S. (2025) · Nutrients · doi:10.3390/nu17213350 · Cited by 24 · see citing works

Circulating Nucleic Acid-Based Biomarkers of Type 2 Diabetes

Padilla-Martínez, F., Wojciechowska, G. E. P., Szczerbiński, Ł., & Kretowski, A. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010295 · Cited by 18 · see citing works

Total Astragalus saponins can reverse type 2 diabetes mellitus-related intestinal dysbiosis and hepatic insulin resistance in vivo

Ma, L., La, X., Zhang, B., Xu, W., Tian, C., Fu, Q., Wang, M., Wu, C., Chen, Z., Chang, H., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1190827 · Cited by 18 · see citing works

Endogenous opiates and behavior: 2019

Bodnar, R. J. (2021) · Peptides · doi:10.1016/j.peptides.2021.170547 · Cited by 17 · see citing works

Morphine mediated neutrophil infiltration in intestinal tissue play essential role in histological damage and microbial dysbiosis

Jalodia, R., Kolli, U., Braniff, R. G., Tao, J., Abu, Y. F., Chupikova, I., Moidunny, S., Ramakrishnan, S., & Roy, S. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2143225 · Cited by 17 · see citing works

Decreased Intestinal Microbiota Diversity Is Associated With Increased Gastrointestinal Symptoms in Patients With Chronic Pancreatitis

McEachron, K. R., Nalluri, H., Beilman, G. J., Kirchner, V. A., Pruett, T. L., Freeman, M. L., Trikudanathan, G., Staley, C. M., & Bellin, M. D. (2022) · Pancreas · doi:10.1097/mpa.0000000000002096 · Cited by 16 · see citing works

The Gut-Brain Axis in Opioid Use Disorder: Exploring the Bidirectional Influence of Opioids and the Gut Microbiome—A Comprehensive Review

Barkus, A., Baltrūnienė, V., Baušienė, J., Baltrūnas, T., Barkienė, L., Kazlauskaitė, P., & Baušys, A. (2024) · Life · doi:10.3390/life14101227 · Cited by 16 · see citing works

The role of gut-immune-brain signaling in substance use disorders

Lucerne, K. E., & Kiraly, D. D. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.005 · Cited by 16 · see citing works

Gut microbiota heterogeneity in non-alcoholic fatty liver disease: a narrative review of drivers, mechanisms, and clinical relevance

Guo, Y., Zhang, N., & Pei, D. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1645298 · Cited by 14 · see citing works

Prevalence of cigarette smoking in Iranian adolescents and young adults: a systematic review and meta-analysis

Aryaie, M., Sharifi, H. P., Khorrami, Z., Ardalan, G., Rajaei, L., Heydari, G., & Shahesmaeili, A. (2021) · Eastern Mediterranean Health Journal · doi:10.26719/emhj.21.018 · Cited by 14 · see citing works

Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Young, P. M., Elghawy, O., Mock, J., Wynter, E., Gentzler, R. D., Martin, L. W., Novicoff, W. M., & Hall, R. D. (2024) · Current Oncology · doi:10.3390/curroncol31010017 · Cited by 13 · see citing works

Gut microbiota in a population highly affected by obesity and type 2 diabetes and susceptibility to COVID-19

Garcı́a-Mena, J., Corona-Cervantes, K., Cuervo-Zanatta, D., Benítez-Guerrero, T., Vélez-Ixta, J. M., Zavala-Torres, N. G., Villalobos-Flores, L. E., Hernández-Quiroz, F., Perez‐Cruz, C., Murugesan, S., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i41.7065 · Cited by 13 · see citing works

Opioid Use and Gut Dysbiosis in Cancer Pain Patients

Coluzzi, F., Scerpa, M. S., Loffredo, C., Borro, M., Pergolizzi, J. V., LeQuang, J. A., Alessandri, E., Simmaco, M., & Rocco, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147999 · Cited by 12 · see citing works

Gut microbiota alterations may increase the risk of prescription opioid use, but not vice versa: A two-sample bi-directional Mendelian randomization study

Lin, L., Lin, J., Qiu, J., Feng, W., Bai, X., Ma, W., Zeng, J., & Lin, D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.994170 · Cited by 12 · see citing works

Astragalus alters gut-microbiota composition in type 2 diabetes mice: clues to its pharmacology

Li, X., Shen, L., & Ji, H. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s203239 · Cited by 12 · see citing works

Gut-Microbiome Implications in Opioid Use Disorder and Related Behaviors

Herlihy, B., & Roy, S. (2022) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2022.10311 · Cited by 10 · see citing works

Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review

Petakh, P., Kamyshna, I. I., & Kamyshnyi, O. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1260633 · Cited by 11 · see citing works

Intestinal barrier damage caused by addictive substance use disorder

Gao, Y., Kong, D., Sun, J., Ma, Z.-X., Wang, G.-Q., Ma, X., Sun, L., Luo, H.-Y., Xu, Y., & Wang, K. (2025) · European journal of medical research · doi:10.1186/s40001-025-02446-1 · Cited by 9 · see citing works

Potential roles of the gut microbiota in the manifestations of drug use disorders

Wang, Z., Hou, C., Chen, L., Zhang, M., & Luo, W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1046804 · Cited by 9 · see citing works

HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects

Satish, S., Abu, Y. F., Gomez, D. R., Dutta, R. K., & Roy, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1156862 · Cited by 9 · see citing works

The bidirectional relationship between opioids and the gut microbiome: Implications for opioid tolerance and clinical interventions

Taboun, Z. S., & Sadeghi, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111142 · Cited by 8 · see citing works

The Bidirectional Interplay Between Substances of Abuse and Gut Microbiome Homeostasis

Borrego-Ruiz, A., & Borrego, J. J. (2025) · Life · doi:10.3390/life15060834 · Cited by 9 · see citing works

Interrelations between Gut Microbiota Composition, Nutrient Intake and Diabetes Status in an Adult Japanese Population

Tamura, A., Murabayashi, M., Nishiya, Y., Mizushiri, S., Hamaura, K., Ito, R., Ono, S., Terada, A., Murakami, H., Tanabe, J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113216 · Cited by 8 · see citing works

The Guts of the Opioid Crisis

Muchhala, K. H., Jacob, J. C., Kang, M., Dewey, W. L., & Akbarali, H. I. (2021) · Physiology · doi:10.1152/physiol.00014.2021 · Cited by 8 · see citing works

Faecal Microbiota Transplantation Modulates Morphine Addictive‐Like Behaviours Through Hippocampal Metaplasticity

Saeedi, N., Pourabdolhossein, F., Dadashi, M., suha, A. J., Janahmadi, M., Behzadi, G., & Hosseinmardi, N. (2025) · Addiction Biology · doi:10.1111/adb.70034 · Cited by 7 · see citing works

Exploring the Gut and Oral Microbiomes in Psychoactive Substance Use: A Scoping Review of Clinical Studies

Barkus, A., Baltrūnienė, V., Barkienė, L., Baušienė, J., Baltrūnas, T., Brazys, M., Rauduvytė, K., Kazlauskaitė, P., & Baušys, A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70165 · Cited by 5 · see citing works

Dietary composition and fasting regimens differentially impact the gut microbiome and short-chain fatty acid profile in a Pakistani cohort

Gul, F., Herrema, H., Ameer, A., Davids, M., Nasir, A., Gerasimidis, K., Ijaz, U. Z., & Javed, S. (2025) · Frontiers in Systems Biology · doi:10.3389/fsysb.2025.1622753 · Cited by 5 · see citing works

Methadone maintenance treatment is more effective than compulsory detoxification in addressing gut microbiota dysbiosis caused by heroin abuse

Yan, P., Ma, H., Tian, W., Liu, J., Yan, X., Ma, L., Wei, S., Zhu, J., Zhu, Y., & Lai, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1283276 · Cited by 5 · see citing works

Opioid use and risk of Clostridioides difficile infection in hospitalized patients: A systematic review and meta-analysis

Gokhale, P., & Zapata, L. V. (2025) · American Journal of Infection Control · doi:10.1016/j.ajic.2025.06.019 · Cited by 4 · see citing works

Probiotic L. reuteri treatment in stressed rats improves maternal care and corrects corticosterone-BDNF-oxytocin balance offering insights for maternal postpartum distress treatment

Benlakehal, R., Gaetano, A., Charlet, R., Bouwalerh, H., Cogez, V., Harduin‐Lepers, A., Sendid, B., Nicoletti, F., Maccari, S., & Morley‐Fletcher, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-05848-7 · Cited by 4 · see citing works

Addiction Susceptibility: Genetic Factors, Personality Traits, and Epigenetic Interactions with the Gut Microbiome

Borrego-Ruiz, A., & Borrego, J. J. (2025) · Genes · doi:10.3390/genes16121447 · Cited by 4 · see citing works

Opioid trail: Tracking contributions to opioid use disorder from host genetics to the gut microbiome

Duffy, E. P., Bachtell, R. K., & Ehringer, M. A. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105487 · Cited by 3 · see citing works

Sex differences in opioid response: a role for the gut microbiome?

Han, C., Manners, M. T., & Robinson, S. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1455416 · Cited by 3 · see citing works

Gut microbiota profiling in injection drug users with and without HIV-1 infection in Puerto Rico

Aluthge, N., Adams, S., Davila, C., Carrasco, N. R. G., Chiou, K. S., Abadie, R., Bennett, S. J., Dombrowski, K., Major, A. M., Valentín-Acevedo, A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1470037 · Cited by 2 · see citing works

Gut microbiota profiles in two New Zealand cohorts with overweight and prediabetes: a Tū Ora/PREVIEW comparative study

Mathrani, A., Lu, L. W., Sequeira, I. R., Silvestre, M. P., Hoggard, M., Barnett, D., Fogelholm, M., Raben, A., Poppitt, S. D., & Taylor, M. W. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1244179 · Cited by 2 · see citing works

Identifying the Role of Vasopressin and Oxytocin in the Microbiota-Gut-Brain-Behavior Axis

Peters, N. V. (2022) · Digital Archive @ GSU · doi:10.57709/14972899 · Cited by 2 · see citing works

Gut Microbiota in Colorectal Cancer Carcinogenesis: The Evolution of Hypotheses

Glazunova, E. V., Kurnosov, A., Molodtsova, P. A., Moskalenko, A. M., Makarov, V. V., & Zlobovskaya, O. A. (2025) · Molecular Biology · doi:10.1134/s0026893325700335 · Cited by 1 · see citing works

The gut-brain axis and inflammatory mediators in suicide and mental disorders with high suicide rates: a review of current evidence

Shamabadi, A., Bahri, R. A., Bafrani, M. A., Karimi, H., Asadigandomani, H., Vahidi, H., & Akhondzadeh, S. (2026) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2026.2636468 · Cited by 2 · see citing works

Predictors of HbA1c among Adipocytokine Biomarkers in African-American Men with Varied Glucose Tolerance

Barengolts, E. I., Akbar, A., Layden, B. T., Eisenberg, Y., Priyadarshini, M., Borgia, J. A., Fhied, C. L., Dugas, L. R., & Salim, M. (2020) · Biomedicines · doi:10.3390/biomedicines8110520 · Cited by 2 · see citing works

DYNAMICS OF CHANGES IN THE MICROBIAL PICTURE OF THE ORAL CAVITY ON THE BACKGROUND OF CHRONIC OPIOID EXPOSURE IN THE EXPERIMENT

Fik, V. B., Mykhalevych, М. M., Подолюк, М. В., Tsytovskyi, M. N., Fedechko, Y. M., & Fedoniuk, L. Y. (2022) · Wiadomości Lekarskie · doi:10.36740/wlek202208209 · Cited by 1 · see citing works

Undiscovered morphine. The effects of the long-term use of the opioids

Żylicz, Z. (2019) · Palliative Medicine in Practice · doi:10.5603/pmpi.2019.0004

¿Bacterias para la tolerancia analgésica a la morfina?

Cobos, E. J. (2019) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2019.3754/2019

The Cross-talk Relationship between Metformin and Gut Microbiota

Mirghani, H. O. (2020) · Sudan Journal of Medical Sciences · doi:10.18502/sjms.v15i4.8165

Gut microbiota and hypertension, diabetes, and other cardiovascular risk factors

Duttaroy, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822405-2.00018-9

Microbial Drug Interactions and Human Health

Ilhan, Z. E., & Herbst‐Kralovetz, M. M. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160950-00120

Gut-brain axis

Abshire, K. M., & Leggio, L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823453-2.00013-8

Gut Microbiota in Type 2 Diabetes

Ganguly, A., & Patra, F. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815324549125010008

Are Bifidobacterium Species Key Players in the Progression of Type 1 Diabetes? A Systematic Review

Vergoz, V., Jeong, D., & Hamilton‐Williams, E. E. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70120

What Is the Involvement of Gut Microbiome in the Pathophysiology of Diabetes?

Kiełbowski, K., Plewa, P., Zadworny, J., Stodolak, P., Jędrasiak, A., Bakinowska, E., & Pawlik, A. (2025) · Biomolecules · doi:10.3390/biom15101463 · Cited by 1 · see citing works

Metagenomic Analysis of Duodenal Microbiota Reveals a Potential Biomarker of Dysbiosis in the Course of Obesity and Type 2 Diabetes: A Pilot Study

Sroka-Oleksiak, A., Młodzińska, A., Bulanda, M., Salamon, D., Major, P., Stanek, M., & Gosiewski, T. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020369 · Cited by 71 · see citing works

Metataxonomic strategy to decipher gut bacteriome biomarkers of type 2 diabetes and obesity in Tunisian population

Fassatoui, M., Pédron, T., Kheriji, N., Hechmi, M., Dallali, H., Jmel, H., Henda, J., Abid, A., SANSONETTI, P. J., & Kéfi, R. (2026) · Bioscience Reports · doi:10.1042/bsr20260157

Gut Microbiota of Obese, Type 2 Diabetic Individuals is Enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after Weight Loss

Remely, M., Hippe, B., Zanner, J., Aumueller, E., Brath, H., & Haslberger, A. G. (2016) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530316666160831093813 · Cited by 143 · see citing works

Oxytocin is lower in African American men with diabetes and associates with psycho-social and metabolic health factors

Eisenberg, Y., Dugas, L. R., Akbar, A., Reddivari, B., Layden, B. T., & Barengolts, E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190301 · Cited by 19 · see citing works

Gut Microbiota Patterns in Obese and Type 2 Diabetes (T2D) Patients from Romanian Black Sea Coast Region

Suceveanu, A., Stoian, A. P., Parepa, I. R., Voinea, C., Hainăroșie, R., Mănuc, D., Niţipir, C., Mazilu, L., & Suceveanu, A. P. (2018) · Revista de Chimie · doi:10.37358/rc.18.8.6512 · Cited by 34 · see citing works